Skip to main content
. 2019 Oct 28;2019(10):CD008521. doi: 10.1002/14651858.CD008521.pub5

2.22. Analysis.

Comparison 2 RV5 versus placebo, Outcome 22 Subgroup analysis: rotavirus diarrhoea of any severity (by G type).